Buscar
Bausch Health Companies Inc
BHCAñadir a la lista de seguimiento
6.890USD
+0.875+14.51%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
2.57BCap. mercado
PérdidaP/E TTM
Más Datos de Bausch Health Companies Inc Compañía
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.
Información de Bausch Health Companies Inc
Símbolo de cotizaciónBHC
Nombre de la empresaBausch Health Companies Inc
Fecha de salida a bolsaSep 20, 1994
Director ejecutivoAppio (Thomas J)
Número de empleados20700
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 20
Dirección2150 St. Elzear Blvd. West
CiudadLAVAL
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísCanada
Código postalH7L 4A8
Teléfono18003611448
Sitio Webhttps://www.bauschhealth.com/
Símbolo de cotizaciónBHC
Fecha de salida a bolsaSep 20, 1994
Director ejecutivoAppio (Thomas J)
Ejecutivos de Bausch Health Companies Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
903.22K
-173.57%
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
367.93K
+27.24%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
300.59K
+15.26%
Mr. Jean-Jacques (JJ) Charhon
Mr. Jean-Jacques (JJ) Charhon
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
186.40K
-136.49%
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
97.07K
+7.05%
Mr. Michael Goettler
Mr. Michael Goettler
Director
Director
76.02K
+60.34%
Ms. Aimee J. Lenar
Ms. Aimee J. Lenar
Executive Vice President, US Pharma
Executive Vice President, US Pharma
15.25K
-187.89%
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mr. John A. Paulson ,
Mr. John A. Paulson ,
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Dr. Richard C. Mulligan, Ph.D.
Dr. Richard C. Mulligan, Ph.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
903.22K
-173.57%
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
367.93K
+27.24%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
300.59K
+15.26%
Mr. Jean-Jacques (JJ) Charhon
Mr. Jean-Jacques (JJ) Charhon
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
186.40K
-136.49%
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
97.07K
+7.05%
Mr. Michael Goettler
Mr. Michael Goettler
Director
Director
76.02K
+60.34%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Bausch Health Companies Inc?
Los cinco principales accionistas de Bausch Health Companies Inc son: Mr. Thomas J. Appio
¿Cuántas instituciones poseen acciones de Bausch Health Companies Inc (BHC)?
A fecha de 2026Q1, 510 instituciones poseen acciones de Bausch Health Companies Inc, con un valor de mercado combinado de aproximadamente 173.34M, lo que representa el 46.41% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -64499603.00.
¿Cuál es la mayor fuente de ganancias de Bausch Health Companies Inc?
El 2026Q1, el segmento empresarial Pharmaceutical Products generó la ganancia más alta para Bausch Health Companies Inc, ascendiendo a 4.75B y representando el 46.24% de la ganancia total.